| Financial Year |
March 31 2023 |
| Monetary Funds |
1,358,223,772.53 |
| Held-for-trading Financial Assets |
80,036,684.87 |
| Notes Receivable |
1,332,175.28 |
| Accounts Receivable |
454,629,547.29 |
| Advances to Suppliers |
49,666,387.99 |
| Other Receivables |
7,281,662.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
632,142,954.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,086,186.53 |
| Total Current Assets |
2,999,246,711.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
236,191,709.49 |
| Investment Properties |
116,223,860.17 |
| Fixed Assetes |
2,473,057,819.00 |
| Under-construction Projects |
1,569,183,681.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
539,012,707.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,638,143.98 |
| Deferred Income Tax Assets |
8,595,561.38 |
| Other Non-Current Assets |
83,187,073.05 |
| Sub-Total of Non-Current Assets |
5,214,735,875.00 |
| Total Assets |
8,213,982,586.99 |
| Short-Term Loans |
302,109,947.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
391,500,000.00 |
| Accounts Payable |
291,719,229.23 |
| Accounts Received In Advance |
4,328,903.58 |
| Employee Compensation Payable |
25,157,167.34 |
| Taxes Payable |
22,329,421.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
216,447,169.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,000,000.00 |
| Other Current Liabilities |
5,987,922.68 |
| Sub-Total of Current Liabilities |
1,335,640,705.33 |
| Long-term Loans |
373,578,687.67 |
| Bonds Payable |
958,303,220.99 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,988,109.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,355,569,879.51 |
| Total Liabilities |
2,691,210,584.84 |
| Paid-In Capital(Or Share Stock) |
1,193,964,858.00 |
| Capital Surplus |
1,809,228,954.71 |
| Surplus Reserve |
222,176,556.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,221,810,811.36 |
| Minority Stockholder's Interest |
4,683,042.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,518,088,959.76 |
| Owner's Equity（Stockholder's Equity） |
5,522,772,002.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,213,982,586.99 |
